ConvaTec Group (LON:CTEC – Get Rating) had its target price hoisted by investment analysts at Barclays from GBX 290 ($3.34) to GBX 295 ($3.40) in a research report issued on Friday, Marketbeat reports. The firm presently has an “overweight” rating on the stock. Barclays‘s target price suggests a potential upside of 31.34% from the company’s current price.
CTEC has been the topic of several other research reports. JPMorgan Chase & Co. boosted their target price on ConvaTec Group from GBX 255 ($2.94) to GBX 275 ($3.17) and gave the company an “overweight” rating in a research note on Friday, August 5th. Berenberg Bank boosted their target price on ConvaTec Group from GBX 250 ($2.88) to GBX 280 ($3.22) and gave the company a “buy” rating in a research note on Thursday, September 8th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a GBX 210 ($2.42) target price on shares of ConvaTec Group in a research note on Thursday, August 11th.
ConvaTec Group Trading Down 2.7 %
LON CTEC opened at GBX 224.60 ($2.59) on Friday. The stock has a market capitalization of £4.59 billion and a price-to-earnings ratio of 7,486.67. The stock’s 50 day moving average price is GBX 214.79 and its two-hundred day moving average price is GBX 218.50. The company has a debt-to-equity ratio of 90.81, a quick ratio of 0.96 and a current ratio of 1.49. ConvaTec Group has a 52 week low of GBX 165.30 ($1.90) and a 52 week high of GBX 256 ($2.95).
Insider Transactions at ConvaTec Group
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn’t Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don’t Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.